QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Closes Firm Commitment Common Stock Offering
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, on Tuesday announced the closing of its underwritten public offering of 806,452 shares of common stock at a price to the public of $6.50 each. The company granted the underwriters a 45-day option to obtain up to an additional 120,967 shares of common stock to cover any overallotments. Before the deduction of underwriting discounts and offering expenses, the company secured gross proceeds of $5.24 million from the offering, which it plans to utilize…
